Monitoring of Red Cell Donor Chimerism in Oncohematological Patients After Allogeneic Hematopoietic Stem Cell Transplantation
Background. Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a definitive therapy for patients with different oncological and hematological diseases. The study of red cell chimerism is a crucial process for diagnosing transplant engraftment and functioning during the post-transplant...
Збережено в:
| Автори: | , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Russo |
| Опубліковано: |
Practical Medicine Publishing House
2023-01-01
|
| Серія: | Клиническая онкогематология |
| Предмети: | |
| Онлайн доступ: | https://bloodjournal.ru/index.php/coh/article/view/11 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|